$ALT

$2.05 -$0.07 (3.3%) Close

$ALT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ALT Management Team

Dr. M. Scot Roberts

Chief Scientific Officer

Age 66

Compensation $2.419M USD

Sex Male

Mr. Raymond Jordt

Chief Business Officer

Age 52

Compensation $2.941M USD

Sex Male

Mr. Gregory Weaver

Chief Financial Officer

Age 69

Compensation -

Sex Male

Dr. Christophe Arbet-Engels

Chief Medical Officer

Age -

Compensation -

Sex Male

Ms. Linda Richardson

Chief Commercial Officer

Age 61

Compensation -

Sex Female

Mr. Jerome Durso

Chairman of the Board

President

Chief Executive Officer

Age 58

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. M. Scot Roberts Chief Scientific Officer	66	$2.419M USD	Male
Mr. Raymond Jordt Chief Business Officer	52	$2.941M USD	Male
Mr. Gregory Weaver Chief Financial Officer	69	-	Male
Dr. Christophe Arbet-Engels Chief Medical Officer	-	-	Male
Ms. Linda Richardson Chief Commercial Officer	61	-	Female
Mr. Jerome Durso Chairman of the Board President Chief Executive Officer	58	-	Male

Board of Directors

From the proxy statement filed Mar 17, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

8.3 years

from year joined

CEO also chairs the board

Yes

Jerome Durso

Director	Age	On board	Independent	Committees	Other public boards	Pay
Jerome Durso Board chair, CEO	58	2025 1 year	Not independent	None stated	None stated	Paid as CEO
John M. Gill	74	2004 22 years	Independent	Audit Committee Nominating and Corporate Governance Committee	None stated	Not stated
Philip L. Hodges	57	2017 9 years	Independent	Audit Committee · Chair Compensation Committee	None stated	Not stated
Diane Jorkasky, M.D.	74	2020 6 years	Independent	Compensation Committee	None stated	Not stated
Teri Lawver	59	2025 1 year	Independent	Nominating and Corporate Governance Committee	None stated	Not stated
Wayne Pisano	71	2018 8 years	Independent	Nominating and Corporate Governance Committee · Chair	Oncolytics Biotech Inc.	Not stated
Mitchel Sayare, Ph.D.	78	2010 16 years	Independent	Audit Committee	None stated	Not stated
Klaus O. Schafer, M.D., MPH	76	2017 9 years	Independent	None stated	None stated	Not stated
Catherine Sohn, Pharm D.	72	2023 3 years	Independent	None stated	Maze Therapeutics	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 17, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$ALT Management Team

Dr. M. Scot Roberts

Mr. Raymond Jordt

Mr. Gregory Weaver

Dr. Christophe Arbet-Engels

Ms. Linda Richardson

Mr. Jerome Durso

Board of Directors

Related-party transactions

No related-party transactions disclosed